Track the DIASORIN stock price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are quoted on IT IT, under the authority of Consob. Operating in the Health Care sector, DIASORIN has published 13 insider filings. Market capitalisation: €3.5bn. The latest transaction was filed on 11 November 2024 (Sale). Among the most active insiders: CHEN MENACHEM EVEN. The full history is openly available.
13
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€17m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN Hold (neutral), based on 12 analysts. Average price target: €69.86.
26Σ signal
Buys ·€17m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,946 of 26,034 companies
63.2
score / 100
Value
61
Quality
66
FCF yld6.1%
Earn yld4.7%
EV/EBITDA11.4x
ROE8.6%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.